To determine if these factors, and sex, could have influenced our results, we performed linear regressions between CYP2C19 mRNA abundance and each NAFLD phenotype with and without correcting for each of these respective covariates. Here, CYP2C19 is linked to metabolic dysfunction-associated steatotic liver disease.